Company File · BSE 524804 · Latest filing Q1 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Aurobindo Pharma Ltd.
Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27
ISIN INE406A01037 · AUROPHARMA · Healthcare › Pharmaceuticals & Biotechnology
About the business
What does Aurobindo Pharma do? It is a large Hyderabad-based maker of generic medicines, selling mainly in the US & Europe. It makes tablets, injectables & active pharmaceutical ingredients (APIs). What is a biosimilar? A close copy of a complex biological drug, & Aurobindo is building biosimilars & vaccines businesses. It has many plants in India & some abroad.
Price & valuation · BSE close, 19 Oct 2026
Above its usual level
- Sales growth
- +16.3%
- Profit growth
- +25.2%
- Op. margin
- 20.6%
- P/E
- 25.2×
- Usual P/E
- 23.1×
- Price/book
- 2.45×
- ROCE
- 12.8%
- ROE
- 9.9%
- Debt/equity
- 0.20×
- Promoter
- 51.88%
- Pledged
- 11.99%
The latest earnings call · Apr to Jun 2026 · transcript filed 13 Aug 2026
The transcript is ready to read; its call notes appear here once they are written.
Is it expensive, and is it a good business?
Key ratios
In short Priced above its own usual level (P/E 25.2× vs 23.1×), earns moderate returns on capital (ROCE 12.8%) and has modest borrowings (debt to equity 0.20×).
What you pay Valuation
Buyers pay about ₹25 for every ₹1 the company earned per share over the last year. Above its 1-year median of 23.1×.
Latest BSE close ÷ last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 19th October 2026.
The share price is 2.5 times the accounting value of each share. Above its 1-year median of 2.2×.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
The market values the company at 2.7 times its yearly sales.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
The whole business (shares plus debt, minus cash) is valued at about 12.8 years of its operating profit.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
The P/E of 25.2 divided by EPS growth of 0.9% (the latest financial year vs the year before). Below 1 is often read as cheap for the growth; above 2 as expensive.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid no dividend in the last 12 months.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Each ₹100 of shareholders' money and debt earned about ₹12.8 before interest & tax.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.
For every ₹100 of shareholders' money, the company earned about ₹9.9 in a year.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.
The money actually tied up in running the business (leaving out spare cash) earned about 11.1% after tax.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.
Every ₹1 of assets generated about ₹0.62 of sales in a year.
Last 12 months' revenue ÷ average total assets. As of 31st March 2026.
Operating profit covered interest costs about 15 times.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.
For every ₹1 of shareholders' money, it has borrowed ₹0.20.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.
Who owns it Ownership & more
The founders or parent group own 51.88% of the company.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th September 2026.
Promoter holding did not change over the last quarter.
Latest quarter's promoter holding minus the previous quarter's. As of 30th September 2026.
Promoter holding, quarter by quarter
- Sep 202651.88%
- Jun 202651.88%
- Mar 202651.82%
- Dec 202551.82%
- Sep 202551.82%
Promoters have pledged 11.99% of their shares (357.9 lakh shares), 6.22% of the company.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th September 2026.
Pledged, quarter by quarter
- Sep 202611.99%
- Jun 202613.75%
- Mar 202623.65%
- Dec 202517.50%
- Sep 202517.50%
After paying for new plant & equipment, operations left ₹2,841 crore of cash.
Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.
Free cash flow, year by year
- FY26₹2,841 Cr
- FY25₹1,957 Cr
Each share has a face (nominal) value of ₹1. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 57.54 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹92,924 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹90,729 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
The company reported ₹3,711 crore of profit over the last four quarters.
Sum of the last four quarters' reported profit after tax. As of 30th June 2026.
Each share earned about ₹64.00 over the last year.
Sum of the last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 30th June 2026.
Each share is backed by about ₹658 of net assets on the books.
Shareholders' equity ÷ shares. As of 31st March 2026.
About ₹20.3 of every ₹100 of sales was left after running costs.
EBITDA ÷ revenue over the last four quarters. As of 30th June 2026.
About ₹11.3 of every ₹100 of sales became profit last quarter.
Profit after tax ÷ revenue for the latest quarter. As of 30th June 2026.
Sales were 16.3% higher than a year earlier.
Latest quarter's revenue vs the same quarter last year. As of 30th June 2026.
Profit was 25.2% higher than a year earlier.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th June 2026.
Short-term assets cover short-term bills 1.81 times.
Current assets ÷ current liabilities. As of 31st March 2026.
Customers take about 77 days to pay.
Trade receivables ÷ last 12 months' revenue × 365. As of 31st March 2026.
Stock on hand equals about 131 days of sales.
Inventories ÷ last 12 months' revenue × 365. As of 31st March 2026.
12.7% of pre-tax profit came from other income (interest, dividends, gains).
Other income ÷ profit before tax, last 12 months. As of 30th June 2026.
Each ₹1 of profit brought in ₹1.58 of operating cash.
Latest full year's cash from operations ÷ profit after tax. As of 31st March 2026.
Cash exceeds borrowings by ₹2,194 crore.
Cash & bank balances − borrowings. As of 31st March 2026.
The company paid about 31.5% of its pre-tax profit as tax.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th June 2026.
Everything the company owns earned 6.5% in a year.
Last 12 months' profit ÷ average total assets. As of 31st March 2026.
Operating profit before interest, depreciation & tax was ₹7,085 crore.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th June 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
The company spent ₹2,686 crore on plant & equipment.
Purchase of property, plant & equipment, latest full year. As of 31st March 2026.
Borrowings stood at ₹7,676 crore.
Current + non-current borrowings. As of 31st March 2026.
Foreign institutions own 17.41%.
Foreign institutional holding from the latest shareholding pattern. As of 30th September 2026.
Domestic institutions own 24.42%.
Domestic institutional holding (mutual funds, insurers, banks, pension funds). As of 30th September 2026.
The highest price in the last year was ₹1,739.95.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 5th October 2026.
The lowest price in the last year was ₹1,080.1.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 24th October 2025.
The share price moved 46.8% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
About 0% of the last year's earnings per share was paid out as dividends.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th June 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 57.54 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 4 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|
| Revenue from operations | 8,286 | 8,646 | 8,853 | 9,150 |
| EBITDA | 1,678 | 1,773 | 1,753 | 1,881 |
| Operating margin | 20.3% | 20.5% | 19.8% | 20.6% |
| One-off items | – | −65.3 | – | −40.2 |
| Profit after tax | 848.1 | 909.8 | 920.8 | 1,032 |
| Profit after tax without one-offs | 848.1 | 958.8 | 920.8 | 1,062 |
| Basic EPS (₹) | 14.61 | 15.67 | 15.86 | 17.86 |
One-off items: exceptional items reported separately in the filing. Profit without one-offs takes them out after tax at 25%.
Latest filings BSE
Corporate announcements 27
- 3 Oct 2026Press Release / Media Release
- 2 Oct 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
- 2 Oct 2026Acquisition
Quarterly results 0
None in the filings we hold.
Conference calls 11
- 21 Sep 2026Analyst / Investor Meet - Intimation
- 11 Sep 2026Analyst / Investor Meet - Intimation
- 11 Sep 2026Analyst / Investor Meet - Intimation
Investor presentations 1
- 5 Aug 2026Investor Presentation
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.